Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab
Bria, E.; Vanni, B.; Cuppone, F.; Calabretta, F.; Campanella, C.; Torsello, A.; Terzoli, E.
I Supplementi di Tumori Official Journal of Societa Italiana di Cancerologia . 3(4): S65-S66
2004
ISSN/ISBN: 2283-5423 PMID: 15206216 Document Number: 567142
Document emailed within 1 workday
Related Documents
Cheson, B.D.; Abrams, J.S.; Arbuck, S.G.; Phillips, P.H. 1994: Clinical trials referral resource. Clinical trials with paclitaxel in metastatic breast cancer Oncology 8(1): 72Hou, M-Mo.; Liu, X.; Wheler, J.; Naing, A.; Hong, D.; Bodurka, D.; Schmeler, K.; Tsimberidou, A.; Janku, F.; Zinner, R.; Piha-Paul, S.; Hu, C-Yuan.; Lu, K.; Kurzrock, R.; Fu, S. 2014: Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program Anticancer Research 34(5): 2349-2355
Hsu, H-Chih.; Chang, H-Kun.; Lin, Y-Chang.; Hseu, S.; Chen, J-Shi.; Yang, T-Shen.; Wang, H-Ming.; Shen, W-Chi. 2009: The role of HER2 in metastatic breast cancer treated with a combination of taxanes and cisplatin Chang Gung Medical Journal 32(1): 33-41
Hirano, T.; Sakurai, K.; Fujisaki, S.; Maeda, T.; Nagashima, S.; Hara, Y.; Tomita, R.; Suzuki, S.; Enomoto, K.; Amano, S. 2012: Lapatinib is useful for metastatic breast cancer patients who cannot be treated with trastuzumab-report of a case Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2045-2047
Hudes, G.R.; Comis, R.L. 1988: Phase 1 and 2 studies of trimetrexate administered in combination with fluorouracil to patients with metastatic cancer Seminars in Oncology 15(2 Suppl 2: 41-45
Muggia, F.M.; Rozencweig, M.; Chiuten, D.F.; Jensen-Akula, M.S.; Charles, L.M.; Kubota, T.T.; Bono, V.H. 1980: Phase Ii trials: use of a clinical tumor panel and overview of current resources and studies Cancer Treatment Reports 64(1): 1-9
Yoshida, T.; Horiguchi, J.; Koibuchi, Y.; Kanoh, T.; Iijima, K.; Yoshida, M.; Kikuchi, M.; Takata, D.; Oyama, T.; Iino, Y.; Morishita, Y. 2004: Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(6): 907-910
Di Lauro, V.; Murrone, A.; Bidoli, E.; Magri, M.D.; Crivellari, D.; Veronesi, A. 2008: Trastuzumab and vinorelbine as highly effective and safe therapy for HER-2-overexpressing metastatic breast cancer. A single institution experience Tumori 94(4): 464-468
Haward, R.A.; Forman, D. 1996: Specialist surgeons and survival in breast cancer. Observational studies are essential Bmj 313(7055): 494; Author Reply 495
Kimura, M.; Sano, M.; Tabei, T.; Asaga, T.; Ando, J.; Fujii, H.; Yamamoto, N.; Kurosumi, M. 2005: Study of three-weekly docetaxel and weekly trastuzumab treatment in HER 2-overexpressing metastatic breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 335-339
McElfish, P.A.; Su, L.J.; Lee, J.Y.; Runnells, G.; Henry-Tillman, R.; Kadlubar, S.A. 2019: Mobile Mammography Screening as an Opportunity to Increase Access of Rural Women to Breast Cancer Research Studies Breast Cancer: Basic and Clinical Research 13: 1178223419876296
Altundag, K. 2017: Predictive markers for trastuzumab-associated cardiac dysfunction in patients with early-stage human epidermal growth factor receptor 2-positive breast cancer receiving trastuzumab Journal of BUON: Official Journal of the Balkan Union of Oncology 22(3): 801
Cheson, B.D.; Phillips, P.H.; Trimble, E. 1994: Clinical trials. Referral resource. Phase Ii Ovarian Cancer Trials Oncology 8(4): 73-74
Trimble, E.L.; Schoenfeldt, M. 2004: Clinical trials referral source. Current randomized phase IIi trials in gynecologic cancer Oncology 18(13): 1642; 1645-1646
Yamazaki, Z.; Kuno, K.; Fukami, A.; Hirose, M.; Oashi, Y. 1971: Clinical studies of breast thermography and its significance as an auxiliary diagnostic test of breast cancer Gan no Rinsho. Japan Journal of Cancer Clinics 17(9): 663-669
Acres, B. 2007: Cancer immunotherapy: phase Ii clinical studies with TG4010 (MVA-MUC1-IL2) Journal of Buon: Official Journal of the Balkan Union of Oncology 12(Suppl 1): S71-S75
Brinkman-Woltjer, L.F.; Vermorken, J.B.; van Groeningen, C.J.; Gall, H.E.; Pinedo, H.M. 1988: Phase i studies as non-therapeutic trials in oncology Nederlands Tijdschrift Voor Geneeskunde 132(51): 2321-2325
Sakurai, T.; Jinta, E.; Suzuma, T.; Yoshimura, G.; Umemura, T.; Sakurai, T. 2012: Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(11): 1703-1706
Lecumberri, Rón.; Páramo, Jé.A.; Rocha, E. 2005: Anticoagulant treatment and survival in cancer patients. The evidence from clinical studies Haematologica 90(9): 1258-1266
Nicholson, B.; Paul, D.; Shyr, Y.; Garrett, M.; Hande, K.R.; Johnson, D.H. 1997: Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: a Vanderbilt Cancer Center phase Ii trial Seminars in Oncology 24(4 Suppl 11: S11